Class information for:
Level 1: ENOXIMONE//AMRINONE//MILRINONE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
3826 1826 28.9 61%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
1446 7310 LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ENOXIMONE Author keyword 64 65% 3% 62
2 AMRINONE Author keyword 41 53% 3% 54
3 MILRINONE Author keyword 35 31% 5% 94
4 PIROXIMONE Author keyword 24 91% 1% 10
5 OLPRINONE Author keyword 14 49% 1% 21
6 PHOSPHODIESTERASE III INHIBITORS Author keyword 12 86% 0% 6
7 PHOSPHODIESTERASE III INHIBITOR Author keyword 11 45% 1% 18
8 OPC 18790 Author keyword 10 73% 0% 8
9 TOBORINONE Author keyword 9 83% 0% 5
10 CAMP PHOSPHODIESTERASE INHIBITOR Author keyword 6 80% 0% 4

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ENOXIMONE 64 65% 3% 62 Search ENOXIMONE Search ENOXIMONE
2 AMRINONE 41 53% 3% 54 Search AMRINONE Search AMRINONE
3 MILRINONE 35 31% 5% 94 Search MILRINONE Search MILRINONE
4 PIROXIMONE 24 91% 1% 10 Search PIROXIMONE Search PIROXIMONE
5 OLPRINONE 14 49% 1% 21 Search OLPRINONE Search OLPRINONE
6 PHOSPHODIESTERASE III INHIBITORS 12 86% 0% 6 Search PHOSPHODIESTERASE+III+INHIBITORS Search PHOSPHODIESTERASE+III+INHIBITORS
7 PHOSPHODIESTERASE III INHIBITOR 11 45% 1% 18 Search PHOSPHODIESTERASE+III+INHIBITOR Search PHOSPHODIESTERASE+III+INHIBITOR
8 OPC 18790 10 73% 0% 8 Search OPC+18790 Search OPC+18790
9 TOBORINONE 9 83% 0% 5 Search TOBORINONE Search TOBORINONE
10 CAMP PHOSPHODIESTERASE INHIBITOR 6 80% 0% 4 Search CAMP+PHOSPHODIESTERASE+INHIBITOR Search CAMP+PHOSPHODIESTERASE+INHIBITOR

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 AMRINONE 127 61% 7% 135
2 MDL 17 043 73 89% 2% 33
3 MILRINONE 48 28% 8% 143
4 MDL 17043 31 92% 1% 12
5 INTRAVENOUS AMRINONE 30 100% 1% 12
6 INTRAVENOUS MILRINONE 27 48% 2% 42
7 1 3 DIHYDRO 4 METHYL 5 4 METHYLTHIO BENZOYL 2H IMIDAZOL 2 ONE 23 100% 1% 10
8 OUTPATIENT DOBUTAMINE 22 81% 1% 13
9 ENOXIMONE 20 47% 2% 31
10 INOTROPIC AGENTS 18 34% 2% 43

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Milrinone: Basic and clinical pharmacology and acute and chronic management 1996 47 24 92%
Parenteral inotropic support for advanced congestive heart failure 1998 55 70 69%
PHARMACOLOGY, MECHANISMS OF ACTION AND USES OF SELECTIVE PHOSPHODIESTERASE INHIBITORS 1992 42 59 69%
NEW POSITIVE INOTROPIC AGENTS IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE - MECHANISMS OF ACTION AND RECENT CLINICAL DEVELOPMENTS .2. 1986 272 90 94%
ELECTROPHYSIOLOGIC AND PROARRHYTHMIC EFFECTS OF INTRAVENOUS INOTROPIC AGENTS 1995 42 63 63%
Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery - a systematic literature review 2005 42 84 45%
Pharmacokinetics and pharmacodynamics of intravenous inotropic agents 2004 41 102 38%
Intravenous milrinone in cardiac surgery 2002 25 39 69%
CURRENT STATUS OF PHOSPHODIESTERASE INHIBITORS IN THE TREATMENT OF CONGESTIVE-HEART-FAILURE 1992 23 135 80%
MILRINONE - A PRELIMINARY REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND THERAPEUTIC USE 1988 54 69 94%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ.
in class
1 DIPARTIMENTO SCI MED BASE PL 1 50% 0.1% 1
2 EMORY CLIN ANESTHESIOL 1 50% 0.1% 1
3 SURG ANAESTHET DOMEST ANIM 1 50% 0.1% 1
4 UNIDAD POSTOPERATORIA CIRUGIA CARDIACA 1 50% 0.1% 1
5 CARDIAC THORAX SURG 0 33% 0.1% 1
6 MED A57 MOLEC CELLULAR MED 0 33% 0.1% 1
7 ZARI 0 33% 0.1% 1
8 MED PHARMACOL AOBA KU 0 25% 0.1% 1
9 ORTHOPAED SURG BIOSTAT 0 25% 0.1% 1
10 NEW ENGLAND REG PRIMATE MED 0 20% 0.1% 1

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000226742 LEVOSIMENDAN//CALCIUM SENSITIZERS//CALCIUM SENSITIZER
2 0.0000202908 TSC 22//VESNARINONE//POSITIVE INOTROPIC ACTIVITY
3 0.0000189001 XAMOTEROL//EPANOLOL//DENOPAMINE
4 0.0000163828 BDF 9148//DPI 201 106//NA CHANNEL MODULATORS
5 0.0000117674 FLOSEQUINAN//BTS 53 554//FIRST DOSE HYPOTENSION
6 0.0000110689 IBOPAMINE//EPININE//NOLOMIROLE
7 0.0000071566 T 0509//ZINTEROL//BETA ADRENERGIC RECEPTOR SUBTYPE
8 0.0000058518 ROLIPRAM//PDE4//PHOSPHODIESTERASE
9 0.0000054045 CHRONIC VOLUME LOAD//CARBON 13 LABELED SUBSTRATES//CLIN PHARMACOL INTERNAL PROPEDEUT
10 0.0000047685 MOUSE LYMPHOID NEOPLASMA P 388//MOUSE MAMMARY CARCINOMA FM 3A//HUMAN HISTIOCYTIC LYMPHOMA U 937